[1] A. A. Jasim and Z. H. A. Al-Asady, “Molecular detection f Klebsiella Oxytoca Isolated from clinical sources,” Plant Arch., vol. 20, no. 1, pp. 2104–2108, 2020.
[2] J. Stewart, L. M. Judd, A. Jenney, K. E. Holt, K. L. Wyres, and J. Hawkey, “Epidemiology and genomic analysis of Klebsiella oxytoca from a single hospital network in Australia,” BMC Infect. Dis., vol. 22, no. 1, pp. 1–10, 2022.
[3] S. Ahmed Hasan and M. Mohammed Bakr, “Bacteriological and Molecular Detection of Klebsiella oxytoca and its Resistance to Antibiotics among Clinical Specimens from Kirkuk, Iraq.,” Inst. Razi. Arch., vol. 77, no. 5, 2022.
[4] J. Yang, H. Long, Y. Hu, Y. Feng, A. McNally, and Z. Zong, “Klebsiella oxytoca complex: update on taxonomy, antimicrobial resistance, and virulence,” Clin. Microbiol. Rev., vol. 35, no. 1, pp. e00006-21, 2022.
[5] R. Herruzo, G. Ruiz, S. Gallego, J. Diez, A. Sarria, and F. Omeñaca, “VIM-Klebsiella oxytoca outbreak in a neonatal intensive care unit. This time it wasn’t the drain,” J. Prev. Med. Hyg., vol. 58, no. 4, p. E302, 2017.
[6] B. Yadav, S. Mohanty, and B. Behera, “Occurrence and Genomic Characteristics of Hypervirulent Klebsiella pneumoniae in a Tertiary Care Hospital, Eastern India,” Infect. Drug Resist., pp. 2191–2201, 2023.
[7] K. L. Wyres, M. M. C. Lam, and K. E. Holt, “Population genomics of Klebsiella pneumoniae,” Nat. Rev. Microbiol., vol. 18, no. 6, pp. 344–359, 2020.
[8] M. Damian, C.-R. Usein, A.-M. Palade, S. Ceciu, and M. Cosman, “Molecular epidemiology and virulence characteristics of Klebsiella pneumoniae strains isolated from hospital-associated infections,” Open Epidemiol. J., vol. 2, no. 1, 2009.
[9] C. A. Hogan, N. Watz, I. Budvytiene, and N. Banaei, “Rapid antimicrobial susceptibility testing by VITEK® 2 directly from blood cultures in patients with Gram-negative rod bacteremia,” Diagn. Microbiol. Infect. Dis., vol. 94, no. 2, pp. 116–121, 2019.
[10] H. Alkofide et al., “Multidrug-resistant and extensively drug-resistant enterobacteriaceae: prevalence, treatments, and outcomes–a retrospective cohort study,” Infect. Drug Resist., pp. 4653–4662, 2020.
[11] J. Sambrook and D. W. Russell, Molecular Cloning: Ch. 8. In Vitro amplification of DNA by the polymerase chain reaction, vol. 2. Cold Spring Harbor Laboratory Press, 2001.
[12] W. P. Herridge, P. Shibu, J. O’Shea, T. C. Brook, and L. Hoyles, “Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses,” J. Med. Microbiol., vol. 69, no. 2, p. 176, 2020.
[13] R. Emad, R. R. Hafidh, and M. Z. Zaman, “Identification of Klebsiella oxytoca by VITEK-2 System in Baghdad Hospitals,” J. Fac. Med. Baghdad, vol. 65, no. 4, 2023.
[14] G. Sibi, P. Kumari, and N. Kabungulundabungi, “Antibiotic sensitivity pattern from pregnant women with urinary tract infection in Bangalore, India,” Asian Pac. J. Trop. Med., vol. 7, pp. S116–S120, 2014.
[15] F. A. Mahdi, A. S. Saadoon, and H. S. Haider, “Prevalence and Antibacterial Resistance of Gram Negative Bacteria Causing Respiratory Tract Infection In Critically Ill Patients.,” J. Fac. Med. Baghdad, vol. 56, no. 3, pp. 273–277, 2014.
[16] M. Liébana-Rodríguez et al., “Outbreaks by Klebsiella oxytoca in neonatal intensive care units: Analysis of an outbreak in a tertiary hospital and systematic review,” Enfermedades Infecc. y Microbiol. Clin. (English ed.), 2023.
[17] G. Li, S. Sun, Z. Y. Zhao, and Y. Sun, “The pathogenicity of rmpA or aerobactin-positive Klebsiella pneumoniae in infected mice,” J. Int. Med. Res., vol. 47, no. 9, pp. 4344–4352, 2019.
[18] N. J. Kandela, “Detection of Extended Spectrum Beta-Lactamase (ESβL) and Klebocin Production from Klebsiella pneumoniae Local Isolates from Urinary Tract Infections,” Al Mustansiriyah J. Pharm. Sci., vol. 9, no. 1, pp. 21–42, 2011.
[19] S. Vergara-López, M. C. Domínguez, M. C. Conejo, Á. Pascual, and J. Rodríguez-Baño, “Wastewater drainage system as an occult reservoir in a protracted clonal outbreak due to metallo-β-lactamase-producing Klebsiella oxytoca,” Clin. Microbiol. Infect., vol. 19, no. 11, pp. E490–E498, 2013.
[20] W.-L. Yu, C.-P. Fung, W.-C. Ko, and Y.-C. Chuang, “Polymerase chain reaction analysis for detecting capsule serotypes K1 and K2 of Klebsiella pneumoniae causing abscesses of the liver and other sites,” J. Infect. Dis., vol. 195, no. 8, p. 1235, 2007.
[21] W.-L. Yu et al., “Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan,” Clin. Infect. Dis., vol. 42, no. 10, pp. 1351–1358, 2006.
[22] E. Ruppé et al., “CTX-M β-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia,” Emerg. Infect. Dis., vol. 15, no. 5, p. 741, 2009.
[23] B. Arikan and A. Aygan, “Resistance variations of third generation of Cephalosporins in some of the Enterobacteriaceae members in hospital sewage,” Int J Agric Biol, vol. 11, pp. 93–96, 2009.
[24] P. Nordmann and L. Poirel, “The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide,” Clin. Microbiol. Infect., vol. 20, no. 9, pp. 821–830, 2014.
[25] R. R. Watkins and R. A. Bonomo, “Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis,” Expert Rev. Anti. Infect. Ther., vol. 11, no. 6, pp. 543–545, 2013.
[26] V. Silago et al., “Existence of multiple ESBL genes among phenotypically confirmed ESBL producing Klebsiella pneumoniae and Escherichia coli concurrently isolated from clinical, colonization and contamination samples from neonatal units at Bugando Medical Center, Mwanza, Tanzania,” Antibiotics, vol. 10, no. 5, p. 476, 2021.
[27] C.-J. Lin, L. K. Siu, L. Ma, Y.-T. Chang, and P.-L. Lu, “Molecular Epidemiology of Ciprofloxacin-Resistant Extended-Spectrum β-Lactamase–Producing Klebsiella pneumoniae in Taiwan,” Microb. Drug Resist., vol. 18, no. 1, pp. 52–58, 2012.
[28] D. L. Paterson et al., “Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases,” Clin. Infect. Dis., vol. 39, no. 1, pp. 31–37, 2004.
)